Main Article Content

Authors

Introduction: Inflammasomes direct the maturation of the cytokines il-1β and il-18; which contribute to the pathogenesis of HIV-1 infection. Given its complexity, it is necessary to search for markers that can identify new therapeutic targets or monitor the immunological status of patients. Therefore, the objective of the present work was to explore the independent effect of the main inflammatory components on
HIV-1 infection. Materials and methods: Researchers conducted an analytical study with 36 HIV+ patients and 36 healthy controls, matched by age and sex. Viral load, cd4+/cd8+ T lymphocytes, lipid profile, C-reactive protein and serum concentrations of il-1β, il-6, and il-18 were quantified. RT-PCR in real time quantified the MRNA of the genes related to the inflammasomes. The statistical analysis based on summary measures, hypothesis tests, and multivariate binary logistic regression. Results: Lower values of HDL and MRNA il-18 and higher mrna NLRP1 and MRNA ASC presented in patients with HIV-1 compared with controls. The values of HDL and MRNA il-18 correlated with lymphocyte counts. The multivariate analysis shows that the CD4 / CD8 ratio, the il-18 MRNA and the ASC MRNA can be the main variables that have an explanatory potential on HIV-1 infection in the study population. Conclusion: The importance of studying inflammasomes was evidenced, given that in the study population they are potential therapeutic targets to reduce the inflammatory response.

Damariz Marin-Palma, MSc, Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia, Universidad Cooperativa de Colombia, Medellín.

Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia, Universidad Cooperativa de Colombia, Medellín.

Jaiberth A. Cardona-Arias, MSc, Escuela de Microbiología, Universidad de Antioquia, Universidad Cooperativa de Colombia, Medellín.

Escuela de Microbiología, Universidad de Antioquia, Universidad Cooperativa de Colombia, Medellín.

Juan Carlos Hernández, Sci Doc, Universidad Cooperativa de Colombia, Medellín.

Universidad Cooperativa de Colombia, Medellín.
Marin-Palma, MSc, D., Cardona-Arias, MSc, J. A., & Hernández, Sci Doc, J. C. (2019). Immunological Factors Related to hiv-1 in Colombian Patients. Revista Ciencias De La Salud, 17(2), 245–258. https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.7927

Im H, Ammit AJ. The NLRP3 inflammasome: role in airway inflammation. Clin Exp Allergy. 2014;44(2):160-72. Doi: 10.1111/cea.12206

Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nature reviews Immunology. 2016;16(7):407-20. Doi: 10.1038/nri.2016.58

McIntire CR, Yeretssian G, Saleh M. Inflammasomes in infection and inflammation. Apoptosis: an international journal on programmed cell death. 2009;14(4):522-35. Doi: 10.1007/s10495-009-0312-3

Aganna E, Martinon F, Hawkins PN, Ross JB, Swan DC, Booth DR, et al. Association of mutations in the nalp3/cias1/pypaf1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis and rheumatism. 2002;46(9):2445-52. Doi: 10.1002/art.10509

Hernandez JC, Latz E, Urcuqui-Inchima S. hiv-1 induces the first signal to activate the NLRP3 inflammasome in monocyte-derived macrophages. Intervirology. 2014;57(1):36-42. Doi: 10.1159/000353902

Boasso A, Shearer GM. Chronic innate immune activation as a cause of hiv-1 immunopathogenesis. Clinical immunology. 2008;126(3):235-42. Doi: 10.1016/j. clim.2007.08.015

Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM, et al. Persistent immune activation in hiv-1 infection is associated with progression to aids. Aids. 2003;17(13):1881-8. Doi: 10.1097/01.aids.0000076311.76477.6e

Neuhaus J, Jacobs DR, Jr., Baker JV, Calmy A, Duprez D, La Rosa A, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with hiv infection. The Journal of infectious diseases. 2010;201(12):1788-95. Doi: 10.1086/652749

Granowitz EV, Saget BM, Wang MZ, Dinarello CA, Skolnik PR. Interleukin 1 induces hiv-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1. Molecular medicine. 1995;1(6):667-77. Doi: 10.1007/BF03401607

Shapiro L, Puren AJ, Barton HA, Novick D, Peskind RL, Shenkar R, et al. Interleukin 18 stimulates hiv type 1 in monocytic cells. Proc Natl Acad Sci U S A. 1998;95(21):12550-5. Doi: https://doi.org/10.1073/pnas.95.21.12550

Feria MG, Taborda NA, Hernández JC, Rugeles MT. hiv replication is associated to inflammasomes activation, il-1beta, il-18 and caspase-1 expression in galt and peripheral blood. PLoS One. 2018;13(4):e0192845. Doi: 10.1371/journal.pone.0192845

Marín-Palma D, Taborda N, Urcuqui-Inchima S, Hernández J. Inflamación y respuesta inmune innata: Participación de las lipoproteínas de alta densidad. IATREIA. 2017 OctDic;30(4):423-35. Doi: 10.17533/udea.iatreia.v30n4a06

Rangaswamy KS. Correlation between High-density Lipoprotein Cholesterol Level and cd4 Cell Count in hiv Patients on nnrti-Based art Regimen at Tertiary Care Hospital in Mysuru. Int J Sci Stud. 2017;5(3):150-4. Doi: 10.17354/ijss/2017/286

Marín-Palma D, Castro G, Cardona-Arias J, Urcuqui-Inchima S, Hernández J. Lower HighDensity Lipoproteins Levels During Human Immunodeficiency Virus Type I Infection Are Associated with Increased Inflammatory Markers and Disease Progression. Front Immunol. 2018;9:1350. Doi: 10.3389/fimmu.2018.01350

Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Medicine. 2008;5(10):e203. Doi: 10.1371/journal.pmed.0050203

Abraham AG, Darilay A, McKay H, Margolick JB, Estrella MM, Palella FJ, Jr., et al. Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study. The Journal of infectious diseases. 2015;212(7):1100-10. Doi: 10.1093/infdis/jiv159

Eckard AR, Rosebush JC, O’Riordan MA, Graves CC, Alexander A, Grover AK, et al. Neurocognitive dysfunction in hiv-infected youth: investigating the relationship with immune activation. Antiviral therapy. 2017;22(8):669-80. Doi: 10.3851/IMP3157

Wiercinska-Drapalo A, Jaroszewicz J, Flisiak R, Prokopowicz D. Plasma interleukin-18 is associated with viral load and disease progression in hiv-1-infected patients. Microbes Infect. 2004;6(14):1273-7. Doi: 10.1016/j.micinf.2004.07.009

Thacker SG, Zarzour A, Chen Y, Alcicek MS, Freeman LA, Sviridov DO, et al. High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation. Immunology. 2016;149(3):306-19. Doi: 10.1111/imm.12638

Thompson MR, Kaminski JJ, Kurt-Jones EA, Fitzgerald KA. Pattern recognition receptors and the innate immune response to viral infection. Viruses. 2011;3(6):920-40. Doi: 10.3390/v3060920

Socias ME, Sued O, Laufer N, Lazaro ME, Mingrone H, Pryluka D, et al. Acute retroviral syndrome and high baseline viral load are predictors of rapid hiv progression among untreated Argentinean seroconverters. J Int AIDS Soc. 2011;14:40. Doi: 10.1186/17582652-14-40

Turk G, Ghiglione Y, Hormanstorfer M, Laufer N, Coloccini R, Salido J, et al. Biomarkers of Progression after hiv Acute/Early Infection: Nothing Compares to cd4(+) T-cell Count? Viruses. 2018;10(1). Doi: 10.3390/v10010034

Gunthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, et al. Antiretroviral Drugs for Treatment and Prevention of hiv Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel. Jama. 2016;316(2):191-210. Doi: 10.1001/ jama.2016.8900

Meintjes G, Moorhouse MA, Carmona S, Davies N, Dlamini S, van Vuuren C, et al. Adult antiretroviral therapy guidelines 2017. South Afr J hiv Med. 2017;18(1):776. Doi: 10.4102/ sajhivmed.v18i1.776

Lu W, Mehraj V, Vyboh K, Cao W, Li T, Routy JP. cd4:cd8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed hiv-positive patients. J Int aids Soc. 2015;18:20052. Doi: 10.7448/IAS.18.1.20052

Bastard JP, Soulie C, Fellahi S, Haim-Boukobza S, Simon A, Katlama C, et al. Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled hiv-infected patients. Antiviral Therapy. 2012;17(5):915-9. Doi: 10.3851/IMP2093

Murday AS, Chaudhry S, Pauza CD. Interleukin-18 activates Vgamma9Vdelta2(+) T cells from hiv-positive individuals: recovering the response to phosphoantigen. Immunology. 2017;151(4):385-94. Doi: 10.1111/imm.12735

Downloads

Download data is not yet available.